Top

Reactions Weekly

Published in:

01-03-2024 | Valsartan | Case report

Atropine/sacubitril/valsartan/torasemide

BRASH syndrome and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Maurer J, et al. Unexpected Case of Sacubitril-Valsartan Induced Brash Syndrome. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B48 [abstract]

Title: Atropine/sacubitril/valsartan/torasemide
BRASH syndrome and lack of efficacy
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Valsartan
Atropine
Torasemide
Acidosis
Hyperkalemia
Metoprolol
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-53932-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Atropine/sacubitril/valsartan/torasemide

BRASH syndrome and lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Antineoplastics

Antineoplastics/cotrimoxazole/folinic-acid

Withania somnifera-related GI disorders and liver injury

Antineoplastics

Antineoplastics

Axicabtagene-ciloleucel